News in the Life Sciences Industry

TAIZHOU, China, June 22, 2020 /PRNewswire/ -- Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA viruses, including Ebola, influenza and COVID-19. No evident adverse reactions have been found since... Read more ››

SYDNEY, June 22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share poster presentations of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most... Read more ››

BOSTON and LONDON, June 16, 2020 /PRNewswire/ -- binx health ltd. today announced the first of its kind private offering for at-home sample collection and contactless courier service for laboratory COVID-19 testing for all residents in the United Kingdom. Leveraging the binx digital platform... Read more ››

ELMSFORD, N.Y., June 16, 2020 /PRNewswire/ -- Read more ››

- Findings from the RELIEF study in France showed for the first time, in the largest retrospective analysis of its kind of nearly 75,000 people living with diabetes, use of the FreeStyle Libre system dramatically decreases diabetic ketoacidosis-related hospitalizations

- Lurbinectedin is approved under "Accelerated Approval" based on overall response rate and duration of response demonstrated in an open-label, monotherapy clinical trial.

- Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers

MANNHEIM, Germany, June 15, 2020 /PRNewswire/ -- Park Systems, a global leader in atomic force microscopy (AFM) announces the opening... Read more ››

This material is intended for global medical media only, excl US.